On November 20, 2023, Nutex Health Inc (NASDAQ: NUTX) opened at $0.2385, lower -4.89% from the last session. During the day, the shares moved up to $0.2385 and dropped to $0.22 before settling in for the closing price of $0.23. Price fluctuations for NUTX have ranged from $0.18 to $2.46 over the past 52 weeks.
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 5317.46%. Company’s average yearly earnings per share was noted 96.27% at the time writing. With a float of $357.78 million, this company’s outstanding shares have now reached $650.22 million.
Considering the fact that the conglomerate employs 1150 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is +6.13, operating margin of -2.09, and the pretax margin is -191.36.
Nutex Health Inc (NUTX) Insider Activity
A key investor’s attitude towards the stock of the Health Information Services industry is another important factor to consider. The insider ownership of Nutex Health Inc is 46.66%, while institutional ownership is 5.24%. The most recent insider transaction that took place on Nov 15, was worth 34,174. In this transaction Chief Operating Officer of this company bought 140,000 shares at a rate of $0.24, taking the stock ownership to the 140,000 shares. Before that another transaction happened on Aug 31, when Company’s Chief Executive Officer bought 152,326 for $0.28, making the entire transaction worth $42,651. This insider now owns 269,322,776 shares in total.
Nutex Health Inc (NUTX) Earnings and Forecasts
If we go through the results of last quarter, which was made public on 9/29/2023, the company posted -$0.01 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at $0) by -$0.01. This company achieved a net margin of -193.70 while generating a return on equity of -496.82. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 96.27% per share during the next fiscal year.
Nutex Health Inc (NASDAQ: NUTX) Trading Performance Indicators
Check out the current performance indicators for Nutex Health Inc (NUTX). In the past quarter, the stock posted a quick ratio of 1.30. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.64. Likewise, its price to free cash flow for the trailing twelve months is 28.94.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.04, a number that is poised to hit -0.01 in the next quarter and is forecasted to reach -0.01 in one year’s time.
Technical Analysis of Nutex Health Inc (NUTX)
Compared to the last year’s volume of 1.85 million, its volume of 0.93 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 16.86%. Additionally, its Average True Range was 0.02.
During the past 100 days, Nutex Health Inc’s (NUTX) raw stochastic average was set at 14.46%, which indicates a significant decrease from 16.75% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 112.59% in the past 14 days, which was higher than the 89.82% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.2127, while its 200-day Moving Average is $0.5593. Nevertheless, the first resistance level for the watch stands at $0.2323 in the near term. At $0.2447, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.2508. If the price goes on to break the first support level at $0.2138, it is likely to go to the next support level at $0.2077. Should the price break the second support level, the third support level stands at $0.1953.
Nutex Health Inc (NASDAQ: NUTX) Key Stats
There are currently 670,782K shares outstanding in the company with a market cap of 147.57 million. Presently, the company’s annual sales total 219,290 K according to its annual income of -424,780 K. Last quarter, the company’s sales amounted to 62,720 K and its income totaled -5,540 K.